EurekAlert! -
20 Dec 2017 07:00
(University of Colorado Anschutz Medical Campus) Researchers from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, selected to estimate the cost-effectiveness of the newly approved CAR-T therapies, have found the clinical benefit may justify the expensive price.
Share this Article